Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Amortizatization of Intangibles (2020 - 2025)

Historic Amortizatization of Intangibles for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $356000.0.

  • Foghorn Therapeutics' Amortizatization of Intangibles fell 8005.6% to $356000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 988.98%. This contributed to the annual value of $4.6 million for FY2024, which is 7400.98% up from last year.
  • As of Q3 2025, Foghorn Therapeutics' Amortizatization of Intangibles stood at $356000.0, which was down 8005.6% from $446000.0 recorded in Q2 2025.
  • Over the past 5 years, Foghorn Therapeutics' Amortizatization of Intangibles peaked at $1.8 million during Q3 2024, and registered a low of -$100000.0 during Q3 2021.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $495000.0 (2023), whereas its average is $526315.8.
  • In the last 5 years, Foghorn Therapeutics' Amortizatization of Intangibles crashed by 980000.0% in 2021 and then surged by 654000.0% in 2022.
  • Quarter analysis of 5 years shows Foghorn Therapeutics' Amortizatization of Intangibles stood at -$97000.0 in 2021, then soared by 691.75% to $574000.0 in 2022, then decreased by 13.76% to $495000.0 in 2023, then soared by 216.97% to $1.6 million in 2024, then plummeted by 77.31% to $356000.0 in 2025.
  • Its Amortizatization of Intangibles was $356000.0 in Q3 2025, compared to $446000.0 in Q2 2025 and $818000.0 in Q1 2025.